Glen Santangelo
Stock Analyst at Jefferies
(2.37)
# 2,375
Out of 4,829 analysts
77
Total ratings
45.83%
Success rate
-1.07%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.11 | +12.52% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $66.30 | +20.66% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $8.77 | +48.23% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $40.01 | +27.47% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $5.01 | +19.76% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $17.59 | +25.07% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $15.82 | +26.42% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $25.12 | -28.34% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.19 | +13.26% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $51.96 | -55.74% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $16.93 | +35.85% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $28.89 | +52.30% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $11.96 | +42.14% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $159.27 | +44.41% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.44 | +2,172.73% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $24.18 | +189.50% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $7.85 | +600.64% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $3.14 | +409.55% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $2.44 | +473.77% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.39 | +698.72% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $59.19 | -22.28% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $90.44 | -11.54% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $4.13 | +577.97% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $25.62 | +173.22% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.84 | +1,654.39% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.02 | -33.77% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.32 | +987.96% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.69 | +875.61% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $66.97 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $693.46 | -75.63% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $148.22 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $68.64 | +19.46% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $181.88 | +37.45% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.22 | +595.19% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.11
Upside: +12.52%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $66.30
Upside: +20.66%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $8.77
Upside: +48.23%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $40.01
Upside: +27.47%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $5.01
Upside: +19.76%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $17.59
Upside: +25.07%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $15.82
Upside: +26.42%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $25.12
Upside: -28.34%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.19
Upside: +13.26%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $51.96
Upside: -55.74%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $16.93
Upside: +35.85%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $28.89
Upside: +52.30%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $11.96
Upside: +42.14%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $159.27
Upside: +44.41%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.44
Upside: +2,172.73%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $24.18
Upside: +189.50%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $7.85
Upside: +600.64%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $3.14
Upside: +409.55%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $2.44
Upside: +473.77%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.39
Upside: +698.72%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $59.19
Upside: -22.28%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $90.44
Upside: -11.54%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $4.13
Upside: +577.97%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $25.62
Upside: +173.22%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.84
Upside: +1,654.39%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.02
Upside: -33.77%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.32
Upside: +987.96%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.69
Upside: +875.61%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $66.97
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $693.46
Upside: -75.63%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $148.22
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $68.64
Upside: +19.46%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $181.88
Upside: +37.45%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.22
Upside: +595.19%